The Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT) applauds the National Comprehensive Cancer Network (NCCN) for its newest updates to the Genetic/Familial High-Risk ...
Pharmacogenetic testing can inform medication choice and adverse effect risk, while questions remain about implementation, data storage, and access in routine care.
Indications for and implications of germline genetic testing (GGT) in patients with prostate cancer have expanded over the past decade, particularly related to precision therapies and management. GGT ...
Even though a large proportion of cancer patients carry genetic mutations that make them more susceptible to cancer, only a small percentage of them — and their family members — undergo potentially ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Current genetic tests often miss crucial large-scale DNA structural changes, like ...
There are different forms of embryo testing. Some tests screen for broader chromosomal abnormalities and cannot guarantee an ...
Genetic testing can help doctors diagnose some neurological disorders, such as Huntington’s disease. It can also provide insights into a person’s risk of future health conditions. Genetic testing ...
A multi-ancestry polygenic risk score improved HCM risk prediction in a diverse U.S. population of more than 258,000 people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results